Compared to Estimates, Chemours (CC) Q4 Earnings: A Look at Key Metrics

Core Viewpoint - Chemours reported a revenue of $1.33 billion for the quarter ended December 2025, reflecting a 2.2% decline year-over-year, with an EPS of $0.05 compared to $0.11 in the same quarter last year, indicating a significant EPS surprise of +2400% against a consensus estimate of $0 [1] Revenue Performance - Revenues from the Other Segment were $12 million, slightly below the average estimate of $12.65 million, marking a year-over-year decline of -7.7% [4] - Titanium Technologies generated revenues of $561 million, exceeding the average estimate of $548.65 million, but still showing an -11.2% year-over-year decrease [4] - Advanced Performance Materials reported revenues of $312 million, surpassing the estimated $302.82 million, yet reflecting a -3.7% change compared to the previous year [4] - Thermal & Specialized Solutions achieved revenues of $444 million, slightly below the estimated $447.37 million, but showing a positive year-over-year change of +13.9% [4] Adjusted EBITDA Analysis - Adjusted EBITDA for Titanium Technologies was $23 million, exceeding the average estimate of $17.47 million [4] - The Other Segment's Adjusted EBITDA was $1 million, compared to the average estimate of $0.87 million [4] - Advanced Performance Materials reported an Adjusted EBITDA of $12 million, significantly lower than the estimated $34.36 million [4] - Thermal & Specialized Solutions had an Adjusted EBITDA of $128 million, which was below the average estimate of $135.12 million [4] Stock Performance - Chemours shares have returned +30.6% over the past month, contrasting with a -0.8% change in the Zacks S&P 500 composite [3] - The stock currently holds a Zacks Rank 4 (Sell), suggesting potential underperformance relative to the broader market in the near term [3]